Oral pressure therapy is a novel non-invasive treatment for obstructive sleep apnea. The published clinical research listed below has evaluated the safety, effectiveness, and tolerability of the system for patients with mild, moderate, and severe OSA.
Publications
Upcoming Presentations
American Thoracic Society 2013
Sunday, May 19, 2013
Safety And Effectiveness Of Oral Pressure Therapy: 3-Month Treatment Evaluation. A99-SLEEP DISORDERED BREATHING:DIAGNOSTIC AND THERAPEUTIC APPROACHES Mini Symposium – Oral Presentation. Abstract A2119
Monday, May 20, 2013
Predicting Response To Oral Pressure Therapy For Obstructive Sleep Apnea. B110-DIAGNOSIS AND MANAGEMENT OF SLEEP APNEA Poster Discussion Session – Poster Board #306. Abstract A3752
SLEEP 2013
SLEEP 2013 Abstract Supplement
Monday, June 3, 2013
Poster Presentation #391: Compliance with Oral Pressure Therapy for Treatment of Obstructive Sleep Apnea.
Wednesday, June 5, 2013
Poster Presentation #504: Oral Pressure Therapy for Obstructive Sleep Apnea in Subjects Without Prior Treatment Experience.
Wednesday, June 5, 2013
Abstract #0354: Examining the Mechanism of Action of a New Device Using Oral Pressure Therapy (OPT) for the Treatment of Patients with OSA. Oral Presentation.
Mechanism of Action
OPT increases the airway in both the anterior-posterior and lateral dimensions.
Upper Airway MRI Images
Am J Respir Crit Care Med 185;2012:A6811[Download the PDF]
European Sleep Research Society, JSR 21 (Suppl. 1);2012:O310[Link to Abstract]
ATLAST Study Results
The ATLAST multicenter, prospective, clinical trial was conducted to determine the safety and effectiveness of the Winx System for the treatment of OSA. Study results demonstrated significant improvements in AHI and ODI for patients with moderate and severe OSA. Treatment was durable over 28 days, and adherence was high, with strong patient and bed partner satisfaction.
- Responders were easily identified, and achieved median AHI reduction from 26.2 to 5.7.
- Median objectively recorded usage per night was 6.0 hours.
- 76% of participants responded they would use the Winx System to treat their OSA.
European Sleep Research Society, JSR 21 (Suppl. 1);2012:P697 [Download the PDF]
European Sleep Research Society, JSR 21 (Suppl. 1); 2012:P696 [Download the PDF]
